Efficacy of intravitreal bevacizumab as adjunctive treatment with pars plana vitrectomy, endolaser photocoagulation, and trabeculectomy for neovascular glaucoma.
Miki
A
A
Oshima
Y
Y
Otori
Y
Y
Kamei
M
M
Tano
Y
Y
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D003131:Combined Modality Therapy; D005260:Female; D015355:Glaucoma, Neovascular / Q000188:drug therapy* / Q000601:surgery*; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D017075:Laser Coagulation / Q000379:methods*; D008297:Male; D008875:Middle Aged; D012166:Retinal Hemorrhage / Q000517:prevention & control; D014130:Trabeculectomy / Q000379:methods*; D016896:Treatment Outcome; D014821:Vitrectomy / Q000379:methods*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab